The terminal lucidity of Nordic Venture

The Nordic venture capital scene has officially entered its most surreal chapter yet, a period I can only describe as terminal lucidity. A medical term to describe a brief, unexpected surge of energy and mental clarity in a dying patient just before the end.

We are witnessing a cognitive dissonance of epic proportions where the quarterly investment figures suggest a thriving renaissance, while the actual economy is gasping for air in the corner.

To understand the true state of the venture scene, I spent some time looking at 2025 funding in the Nordics using Nordic9 (thanks Dragos!).

In Sweden and Finland, the numbers didn't just climb, they teleported. We saw Sweden hit a billion dollars in a single quarter and Finland skyrocket by six hundred percent, yet if you peel back the sticker price, you find a market that has effectively stopped being a market and has instead become a high-stakes lifeboat operation for a handful of chosen ones.

The sheer concentration is staggering. When a single health-tech giant in Finland accounts for nearly two-thirds of the entire country’s investment volume, or two AI firms in Sweden soak up half the quarter's capital, we aren't looking at a broad-based recovery. We are looking at the bimodal survival of the fittest.

Global tier-one funds and sovereign wealth have decided that if the world is going to burn, they want their money locked inside the most fortified bunkers available. They are over-feeding the unicorns while the rest of the ecosystem—the biotechs, the manufacturers, and the SaaS builders who don't have a celebrity athlete on the cap table—is left to fight over the crumbs of bridge rounds and unvalued extensions.

Across the region, the symptoms of this strange euphoria vary but the diagnosis is the same. In Iceland, the economy is being kept on a drip-feed of pension fund capital and land-based salmon projects, a desperate hedge for protein and stability in an unstable world. In Norway, we see a chemical life-support system where radiopharmaceuticals and state-backed energy plays provide the illusion of activity while interest rates crush the middle market. Denmark, meanwhile, is living in a state-sponsored hallucination where the sheer gravity of Novo Nordisk and government funds like EIFO prevents a total blackout, masking a graveyard of quiet down-rounds and undisclosed failures.

This is the great disconnect of 2026. We are being told the patient is waking up because their heart rate spiked, but that spike was an adrenaline shot, not a sign of health.

The money flowing in right now isn't betting on a glorious 2026, it is betting that these specific fortresses can survive the collapse of everything else.

It is a calculated, predatory, and deeply un-democratic distribution of capital that rewards the giants and ignores the pioneers. We are watching the formation of a corporate oligarchy in real-time, fueled by a fear of holding cash and a desperate need for a lifeboat.

The better the numbers look, the more worried you should probably be about the organs they aren't showing you.